Equities

Verici DX PLC

VRCI:LSE

Verici DX PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3.50
  • Today's Change0.00 / 0.00%
  • Shares traded135.13k
  • 1 Year change-48.15%
  • Beta0.6427
Data delayed at least 20 minutes, as of Oct 31 2024 12:58 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Verici DX PLC fell by 7.16m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 7.16m for operations while cash used for investing totalled 231.00k.
Cash flow per share-0.016
Price/Cash flow per share--
Book value per share0.0314
Tangible book value per share0.0247
More ▼

Balance sheet in USDView more

Verici DX PLC uses little debt in its capital structure as supported by a debt to capital ratio of 1.83%.
Current ratio3.99
Quick ratio--
Total debt/total equity0.0187
Total debt/total capital0.0183
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.